RJA
VIVS

Raymond James & Associates’s VivoSim Labs VIVS Stock Holding History

Raymond James & Associates’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$9.99K Hold
1,635
– – ﹤0.01% 3972
2024
Q2 		$15K Sell
1,635
-17
-1% -$201 ﹤0.01% 3914
2024
Q1 		$20.4K Hold
1,652
– – ﹤0.01% 3871
2023
Q4 		$22K Buy
+1,652
New +$24.5K ﹤0.01% 3764
2021
Q1 		– Sell
-957
Closed -$141K – 4126
2020
Q4 		$141K Buy
+957
New +$109K ﹤0.01% 3499
2020
Q3 		– Sell
-177
Closed -$23K – 3712
2020
Q2 		$23K Buy
177
+49
+38% +$5.97K ﹤0.01% 3434
2020
Q1 		$13K Sell
128
-18
-12% -$1.45K ﹤0.01% 3425
2019
Q4 		$12K Sell
146
-7
-5% -$655 ﹤0.01% 3630
2019
Q3 		$10K Sell
153
-51
-25% -$4.29K ﹤0.01% 3566
2019
Q2 		$26K Buy
204
+52
+34% +$9.83K ﹤0.01% 3551
2019
Q1 		$36K Buy
152
+71
+88% +$17.9K ﹤0.01% 3498
2018
Q4 		$19K Sell
81
-54
-40% -$13.6K ﹤0.01% 3438
2018
Q3 		$37K Hold
135
– – ﹤0.01% 3510
2018
Q2 		$46K Buy
135
+21
+18% +$6.92K ﹤0.01% 3445
2018
Q1 		$28K Sell
114
-15
-12% -$4.38K ﹤0.01% 3364
2017
Q4 		$42K Sell
129
-64
-33% -$23.8K ﹤0.01% 3296
2017
Q3 		$103K Buy
193
+91
+89% +$48.4K ﹤0.01% 3178
2017
Q2 		$64K Sell
102
-7
-6% -$4.71K ﹤0.01% 3163
2017
Q1 		$83K Hold
109
– – ﹤0.01% 3097
2016
Q4 		$89K Buy
109
+11
+11% +$8.73K ﹤0.01% 3046
2016
Q3 		$89K Sell
98
-4
-4% -$3.92K ﹤0.01% 3020
2016
Q2 		$91K Buy
102
+29
+40% +$19.5K ﹤0.01% 2821
2016
Q1 		$38K Buy
+73
New +$37.1K ﹤0.01% 2811
2015
Q2 		– Sell
-290
Closed -$247K – 2453
2015
Q1 		$247K Buy
+290
New +$401K ﹤0.01% 2272
2014
Q4 		– Sell
-139
Closed -$213K – 2317
2014
Q3 		$213K Sell
139
-54
-28% -$97.9K ﹤0.01% 2138
2014
Q2 		$386K Sell
193
-229
-54% -$384K ﹤0.01% 1958
2014
Q1 		$773K Buy
+422
New +$980K 0.01% 1565

Other funds holding VIVS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Raymond James & Associates's VIVS Position: Q3 2024 in Review

Raymond James & Associates held its VivoSim Labs (VIVS) position steady in Q3 2024 at 1,635 shares worth $9.99K. The position accounts for ﹤0.01% of the portfolio, ranked #3972.

Raymond James & Associates first reported a position in VIVS in Q1 2014 and has held it in 27 quarters since. The position peaked at $773K in Q1 2014. 29 funds tracked by Wall St. Rank hold VIVS as of Q3 2024.

  • Raymond James & Associates held 1,635 shares of VivoSim Labs worth $9.99K as of Q3 2024.
  • Raymond James & Associates left its VivoSim Labs share count unchanged in Q3 2024.
  • VivoSim Labs made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3972 holding.
  • Raymond James & Associates first reported a position in VivoSim Labs in Q1 2014 and has held it in 27 quarters since.
  • Raymond James & Associates's VivoSim Labs position peaked at $773K in Q1 2014.
  • 29 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.